Abstract:Roberto W Dal Negro, 1 Paola Turco, 1 Massimiliano Povero 2 1 National Centre for Respiratory Pharmacoeconomics and Pharmacoepidemiology - CESFAR, Verona, Italy; 2 AdRes Health Economics and Outcomes Research, Turin, Italy Correspondence: Massimiliano Povero, Email Background: Chronic Obstructive Pulmonary Disease (COPD) is a respiratory condition characterized by heterogeneous abnormalities of the airways and lung parenchyma that cause different clinical presentations. The assessment of the prevailing pathogenetic components underlying COPD is not usually pursued in daily practice, also due to technological limitations and cost. Aim: To assess non-invasively the lung emphysema component of COPD by the simultaneous measurement of DL NO and DL CO via a single-breath (sDL NO and sDL CO ). Methods: COPD patients aged ≥ 40 years of both genders were recruited consecutively and labelled by computed tomography as "with significant" emphysema (> 10% of CT lung volume) or "with negligible" emphysema otherwise. Current lung function tests such as sDL NO , sDL CO and Vc (the lung capillary blood volume) were measured. All possible subsets of independent spirometric and diffusive parameters were tested as predictors of emphysema, and their predicted power compared to each parameter alone by ROC analysis and area under the curve (AUC). Results: Thirty-one patients with "significant emphysema" were compared to thirty-one with "negligible emphysema". FEV 1 and FEV1/FVC seemed to be the best spirometric predictors (AUC 0.80 and 0.81, respectively), while sDL CO and Vc had the highest predicted power among diffusive parameters (AUC 0.92 and 0.94, respectively). sDL CO and Vc values were the parameters most correlated to the extent of CT emphysema. Six subsets of independent predictors were identified and included at least one spirometric and one diffusive parameter. According to goodness-to-fit scores (AIC, BIC, log-likelihood and pseudo R 2 ), RV coupled with sDL CO or Vc proved the best predictors of emphysema. Conclusion: When investigating the parenchymal destructive component due to emphysema occurring in COPD, sDL NO , sDL CO and Vc do enhance the predictive power of current spirometric measures substantially. sDL NO , sDL CO and Vc contribute to phenotype of the main pathogenetic components of COPD easily and with high sensitivity. Organizational problems, radiation exposure, time and costs could be reduced, while personalized and precision medicine could be noticeably implemented. Keywords: COPD, parenchymal destruction, emphysema, lung capillary blood volume, simultaneous single-breath NO and CO diffusing capacity, precision medicine Chronic obstructive pulmonary disease (COPD) is a pathological condition of the lung that is characterized by persistent respiratory symptoms (cough, expectoration, dyspnea) due to heterogeneous disorders affecting the airways and/or the lung parenchyma to a variable extent. 1 Though characterized by significant progression and by huge epidemiological and socio-economic impact worldwide, 2–4 Nevertheless, COPD is described as a preventable and treatable condition. 1 It is known since long ago that the pathogenetic components underlying COPD can variably involve all structures of lung units, such as the conductive airways, the small airways and/or the alveoli, the capillary vasculature included. 5–7 Such a pathogenetic heterogeneity entails different clinical presentations of COPD: the clinical phenotypes of COPD. 8–19 Different COPD phenotypes can be obviously characterized by variable responses to therapeutic regimens due to the variable extent of reversible and irreversible components of structural disorders occurring in the lung, and consequently different short- and long-term outcomes can be expected. Unfortunately, respiratory conditions characterized by the predominant airway involvement and those where the parenchymal destruction is prevailing are currently included in the same comprehensive term "COPD", both in clinical practice and in the vast majority of RCTs. In the aim of defining the right pattern of lung function occurring in COPD and the existence of some destructive parenchymal components, measurements of diffusing capacity for carbon monoxide (DL CO ) are currently recommended together to the assessment of static and dynamic volumes, forced flows, airway resistances, and residual volume. However, due to the slow binding of CO with intracapillary hemoglobin (Hb), usual measurements of DL CO are consi -Abstract Truncated-

[Profile of patients evaluated with the Carbon Monoxide Diffusion Capacity Test: A Chilean experience]

Isolated abnormal diffusing capacity for carbon monoxide (iso↓DLco) is associated with increased respiratory symptom burden in people with HIV infection

Impaired diffusing capacity and COPD incidence in adults with symptoms and normal spirometry

The role of lung diffusing capacity for carbon monoxide in Pulmonary Langerhans Cell Histiocytosis

Measuring lung diffusing capacity: an opportunity for improved medical surveillance and disability evaluation of coal miners

Pulmonary diffusing capacity among individuals recovering from mild to moderate COVID-19: a cross-sectional study

Diffusing capacity in chronic obstructive pulmonary disease assessment: A meta-analysis

Validation and reproducibility of the lung function questionnaire (LFQ) for the diagnosis of COPD in Colombia

Single-Breath Simultaneous Measurement of DLNO and DLCO as Predictor of the Emphysema Component in COPD – A Retrospective Observational Study

Elevated plasma levels of epithelial and endothelial cell markers in COVID-19 survivors with reduced lung diffusing capacity six months after hospital discharge

Comparison between single breath method and intrabreath method for measuring carbon monoxide diffusing capacity

Diffusing capacity of the lung for carbon monoxide: association with long-term outcomes after lung transplantation in a 20-year longitudinal study

Comparison of diffusing capacity of carbon monoxide (DLCO) and total lung capacity (TLC) between Indigenous Australians and Australian Caucasian adults

Measurement of diffusion lung capacity (DLCO) in silicosis patients: Correlation with radiographic abnormalities on high-resolution CT scan chest

Diagnosis of Interstitial Lung Disease in Patients with Connective Tissue Disease by the Diffusing Capacity of Carbon Monoxide.

Single Breath Diffusing Capacity for Carbon Monoxide: Effects of Adjustment for Inspired Volume Dead Space, Carbon Dioxide, Hemoglobin and Carboxyhemoglobin

Resting diffusing capacity and severity of radiographic disease predict gas exchange abnormalities with exercise in former US coal miners

Persistence of Diffusion Capacity Impairment and Its Relationship with Dyspnea 12 Months after Hospitalization for COVID-19

Low-Carbon Monoxide Diffusing Capacity, Patient-Reported Measures and Reduced Nailfold Capillary Density Are Associated with Interstitial Lung Disease in Systemic Sclerosis

Resolving the Complexity: A Comprehensive Review on Carbon Monoxide Diffusion Capacity in Chronic Obstructive Pulmonary Disease Patients

Chronic Airflow Limitation, Emphysema and Impaired Diffusing Capacity in Relation to Smoking Habits in a Swedish Middle-Aged Population